Extrahepatic Anomalies in Infants With Biliary Atresia: Results of a Large Prospective North American Multicenter Study

The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enroll...

Full description

Saved in:
Bibliographic Details
Published inHepatology (Baltimore, Md.) Vol. 58; no. 5; pp. 1724 - 1731
Main Authors Schwarz, Kathleen B., Haber, Barbara H., Rosenthal, Philip, Mack, Cara L., Moore, Jeffrey, Bove, Kevin, Bezerra, Jorge A., Karpen, Saul J., Kerkar, Nanda, Shneider, Benjamin L., Turmelle, Yumirle P., Whitington, Peter F., Molleston, Jean P., Murray, Karen F., Ng, Vicky L., Romero, René, Wang, Kasper S., Sokol, Ronald J., Magee, John C.
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health, Inc 01.11.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%). Conclusion: This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome. (Hepatology 2013;58:1724–1731)
AbstractList The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%).UNLABELLEDThe etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%).This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome.CONCLUSIONThis study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome.
The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%). Conclusion: This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome. (Hepatology 2013;58:1724-1731) [PUBLICATION ABSTRACT]
The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%). This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome.
The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American Childhood Liver Disease Research and Education Network to analyze patterns of anomalies in infants with BA. In all, 289 infants who were enrolled in the prospective database prior to surgery at any of 15 participating centers were evaluated. Group 1 was nonsyndromic, isolated BA (without major malformations) (n = 242, 84%), Group 2 was BA and at least one malformation considered major as defined by the National Birth Defects Prevention Study but without laterality defects (n = 17, 6%). Group 3 was syndromic, with laterality defects (n = 30, 10%). In the population as a whole, anomalies (either major or minor) were most prevalent in the cardiovascular (16%) and gastrointestinal (14%) systems. Group 3 patients accounted for the majority of subjects with cardiac, gastrointestinal, and splenic anomalies. Group 2 subjects also frequently displayed cardiovascular (71%) and gastrointestinal (24%) anomalies; interestingly, this group had genitourinary anomalies more frequently (47%) compared to Group 3 subjects (10%). Conclusion: This study identified a group of BA (Group 2) that differed from the classical syndromic and nonsyndromic groups and that was defined by multiple malformations without laterality defects. Careful phenotyping of the patterns of anomalies may be critical to the interpretation of both genetic and environmental risk factors associated with BA, allowing new insight into pathogenesis and/or outcome. (Hepatology 2013;58:1724–1731)
Author Ng, Vicky L.
Whitington, Peter F.
Schwarz, Kathleen B.
Karpen, Saul J.
Moore, Jeffrey
Magee, John C.
Haber, Barbara H.
Murray, Karen F.
Wang, Kasper S.
Shneider, Benjamin L.
Molleston, Jean P.
Turmelle, Yumirle P.
Bezerra, Jorge A.
Mack, Cara L.
Romero, René
Bove, Kevin
Kerkar, Nanda
Sokol, Ronald J.
Rosenthal, Philip
Author_xml – sequence: 1
  givenname: Kathleen B.
  surname: Schwarz
  fullname: Schwarz, Kathleen B.
  organization: Johns Hopkins Medical Institutions
– sequence: 2
  givenname: Barbara H.
  surname: Haber
  fullname: Haber, Barbara H.
  organization: Children's Hospital of Philadelphia
– sequence: 3
  givenname: Philip
  surname: Rosenthal
  fullname: Rosenthal, Philip
  organization: UCSF School of Medicine
– sequence: 4
  givenname: Cara L.
  surname: Mack
  fullname: Mack, Cara L.
  organization: University of Colorado School of Medicine
– sequence: 5
  givenname: Jeffrey
  surname: Moore
  fullname: Moore, Jeffrey
  organization: University of Michigan School of Public Health
– sequence: 6
  givenname: Kevin
  surname: Bove
  fullname: Bove, Kevin
  organization: Cincinnati Children's Hospital Medical Center
– sequence: 7
  givenname: Jorge A.
  surname: Bezerra
  fullname: Bezerra, Jorge A.
  organization: Cincinnati Children's Hospital Medical Center
– sequence: 8
  givenname: Saul J.
  surname: Karpen
  fullname: Karpen, Saul J.
  organization: Texas Children's Hospital
– sequence: 9
  givenname: Nanda
  surname: Kerkar
  fullname: Kerkar, Nanda
  organization: Mount Sinai School of Medicine
– sequence: 10
  givenname: Benjamin L.
  surname: Shneider
  fullname: Shneider, Benjamin L.
  organization: Children's Hospital Pittsburgh of UPMC
– sequence: 11
  givenname: Yumirle P.
  surname: Turmelle
  fullname: Turmelle, Yumirle P.
  organization: Washington University
– sequence: 12
  givenname: Peter F.
  surname: Whitington
  fullname: Whitington, Peter F.
  organization: Children's Memorial Hospital
– sequence: 13
  givenname: Jean P.
  surname: Molleston
  fullname: Molleston, Jean P.
  organization: Indiana University
– sequence: 14
  givenname: Karen F.
  surname: Murray
  fullname: Murray, Karen F.
  organization: Seattle Children's and University of Washington
– sequence: 15
  givenname: Vicky L.
  surname: Ng
  fullname: Ng, Vicky L.
  organization: University of Toronto
– sequence: 16
  givenname: René
  surname: Romero
  fullname: Romero, René
  organization: Emory University
– sequence: 17
  givenname: Kasper S.
  surname: Wang
  fullname: Wang, Kasper S.
  organization: Keck School of Medicine University of Southern California
– sequence: 18
  givenname: Ronald J.
  surname: Sokol
  fullname: Sokol, Ronald J.
  organization: University of Colorado School of Medicine
– sequence: 19
  givenname: John C.
  surname: Magee
  fullname: Magee, John C.
  organization: University of Michigan Medical School
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23703680$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtv1DAURi1URKcDC_4AssQGFmn9SJyE3VANtNIAFQ-xtPy4oa4Se2o7lPn3GGa6qWDju_D5Pl2de4KOfPCA0HNKTikh7OwatqdMNJQ9QgvasLbivCFHaEFYS6qe8v4YnaR0Qwjpa9Y9QceMt4SLjizQ3fpXjqoUqOwMXvkwqdFBws7jSz8onxP-7vI1futGp-IOr3KE5NQb_BnSPJbfMGCFNyr-AHwVQ9qCye4n4I8hltRqguiM8vhDYZ0BnyHiL3m2u6fo8aDGBM8Oc4m-vVt_Pb-oNp_eX56vNpXhXceqQYDtFLfaNHRorFaaU9WxwQ4dYUPdCq0JtQq4EgSssKJmrTZMaWKZbhvCl-jVvncbw-0MKcvJJQPjqDyEOUla96TrO0FZQV8-QG_CHH3ZrlC16Lloy7NELw7UrCewchvdVMTIe6UFONsDpuhIEQZpXC52gy-i3SgpkX-OJotz-fdoJfH6QeK-9F_sof3OjbD7Pygv1lf7xG9CkKbQ
CODEN HPTLD9
CitedBy_id crossref_primary_10_1097_CNQ_0000000000000121
crossref_primary_10_3389_fimmu_2020_00329
crossref_primary_10_1016_j_pepo_2017_03_024
crossref_primary_10_1016_j_transproceed_2016_01_029
crossref_primary_10_1016_j_jcmgh_2015_04_001
crossref_primary_10_3389_fphys_2020_538701
crossref_primary_10_1016_j_epag_2017_12_001
crossref_primary_10_1097_CLD_0000000000000150
crossref_primary_10_1016_j_dld_2021_09_011
crossref_primary_10_1016_j_jpedsurg_2017_08_048
crossref_primary_10_1016_j_clp_2022_07_006
crossref_primary_10_1016_j_epsc_2022_102339
crossref_primary_10_1016_j_jpeds_2022_03_038
crossref_primary_10_1097_MPG_0000000000002414
crossref_primary_10_1016_j_sempedsurg_2025_151475
crossref_primary_10_1097_MPG_0000000000000755
crossref_primary_10_1007_s40477_024_00938_0
crossref_primary_10_1002_hep_29905
crossref_primary_10_1097_PAS_0000000000000755
crossref_primary_10_1002_humu_22786
crossref_primary_10_1097_MOP_0000000000001380
crossref_primary_10_1016_j_jpedsurg_2017_11_018
crossref_primary_10_1097_MPG_0000000000002450
crossref_primary_10_3389_fphar_2023_1173542
crossref_primary_10_3389_fped_2022_918130
crossref_primary_10_1007_s00261_016_0865_x
crossref_primary_10_31744_einstein_journal_2022RC0072
crossref_primary_10_1007_s40139_014_0040_4
crossref_primary_10_1097_HEP_0000000000000029
crossref_primary_10_1016_j_pathol_2021_09_023
crossref_primary_10_1542_peds_2015_3570
crossref_primary_10_1002_cld_428
crossref_primary_10_1007_s12519_018_0203_1
crossref_primary_10_1371_journal_pone_0138381
crossref_primary_10_1097_MD_0000000000016761
crossref_primary_10_1542_peds_2020_038596
crossref_primary_10_3348_jksr_2022_0090
crossref_primary_10_3389_fphys_2020_00966
crossref_primary_10_1016_j_jhep_2023_07_039
crossref_primary_10_1038_s41598_020_59379_4
crossref_primary_10_1016_j_jpedsurg_2015_08_040
crossref_primary_10_3390_diagnostics6010005
crossref_primary_10_1007_s00383_017_4172_6
crossref_primary_10_1038_nrgastro_2015_74
crossref_primary_10_2174_1573396318666220510130259
crossref_primary_10_1002_hep_32800
crossref_primary_10_1111_jgh_14575
crossref_primary_10_3928_19382359_20181018_01
crossref_primary_10_1136_archdischild_2020_319122
crossref_primary_10_1016_j_asjsur_2016_04_003
crossref_primary_10_1016_j_nrleng_2020_07_001
crossref_primary_10_1136_flgastro_2020_101554
crossref_primary_10_3389_fimmu_2023_1206025
crossref_primary_10_1002_wsbm_1303
crossref_primary_10_1097_PEC_0000000000001467
crossref_primary_10_1016_j_cld_2022_03_001
crossref_primary_10_1002_bdr2_1145
crossref_primary_10_1159_000371694
crossref_primary_10_1186_s12887_022_03491_z
crossref_primary_10_1111_liv_14800
crossref_primary_10_1111_petr_14357
crossref_primary_10_1242_dmm_049326
crossref_primary_10_1053_j_semdp_2019_07_004
crossref_primary_10_1016_j_clinre_2019_06_006
crossref_primary_10_1177_03000605211012596
crossref_primary_10_1016_j_nrl_2019_02_001
crossref_primary_10_1016_j_jpeds_2014_05_038
crossref_primary_10_1371_journal_pgen_1007532
crossref_primary_10_1002_ajmg_a_63185
crossref_primary_10_1097_PAS_0000000000001146
crossref_primary_10_1002_hep_30515
crossref_primary_10_1007_s00247_021_05034_7
crossref_primary_10_1016_j_surg_2017_04_013
crossref_primary_10_1016_j_humpath_2014_01_002
crossref_primary_10_1097_MOG_0000000000000509
crossref_primary_10_1007_s00247_020_04840_9
crossref_primary_10_1111_hepr_13060
crossref_primary_10_1016_j_cmrp_2019_01_007
crossref_primary_10_4103_jwas_jwas_195_22
crossref_primary_10_1016_j_surg_2014_08_042
crossref_primary_10_1038_s41572_024_00533_x
crossref_primary_10_1186_s12920_017_0259_0
crossref_primary_10_1038_s41598_019_41148_7
crossref_primary_10_1002_jgh3_12980
crossref_primary_10_1007_s00247_021_05148_y
crossref_primary_10_1097_MPG_0000000000001334
crossref_primary_10_1136_bcr_2018_226222
crossref_primary_10_1016_j_surg_2018_12_003
crossref_primary_10_1155_2015_697238
crossref_primary_10_1016_j_jpeds_2018_04_001
crossref_primary_10_1097_MPG_0000000000000569
crossref_primary_10_1002_hep_32107
crossref_primary_10_1016_j_jhep_2016_04_032
crossref_primary_10_1097_AIA_0000000000000138
crossref_primary_10_3389_fphys_2021_658518
crossref_primary_10_1038_s41390_025_03804_9
Cites_doi 10.1186/1471-2334-5-108
10.1111/j.1478-3231.2011.02578.x
10.1007/s00345-004-0405-0
10.1172/JCI200421153
10.1002/ajmg.1320450606
10.1093/brain/123.6.1102
10.1016/0167-5699(93)90244-F
10.1586/egh.09.61
10.1016/j.jaut.2006.01.001
10.1002/hep.24106
10.1055/s-0029-1233533
10.1007/s00383-004-1203-x
10.1016/S0140-6736(09)60946-6
10.1016/j.jpeds.2006.05.030
10.1055/s-2007-985068
10.1111/j.1442-200X.2009.03014.x
10.1016/j.jpedsurg.2003.09.044
10.1053/j.sempedsurg.2012.05.003
ContentType Journal Article
Copyright 2013 by the American Association for the Study of Liver Diseases
2013 by the American Association for the Study of Liver Diseases.
Copyright_xml – notice: 2013 by the American Association for the Study of Liver Diseases
– notice: 2013 by the American Association for the Study of Liver Diseases.
CorporateAuthor Childhood Liver Disease Research and Education Network
CorporateAuthor_xml – name: Childhood Liver Disease Research and Education Network
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
H94
K9.
7X8
DOI 10.1002/hep.26512
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
AIDS and Cancer Research Abstracts
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1527-3350
EndPage 1731
ExternalDocumentID 3112369421
23703680
10_1002_hep_26512
HEP26512
Genre article
Multicenter Study
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: National Center for Research Resources
  funderid: NIH (5M01 RR00069 (Denver); UL1RR025780 (Denver); UL1RR024153 (Pittsburgh); UL1RR024134 (Philadelphia); UL1RR024131 (San Francisco); UL1RR025005 (Baltimore); UL1RR025741 (Chicago)
– fundername: The National Institute of Diabetes, Digestive and Kidney Diseases
  funderid: U54DK078377; DK 62530 (Baltimore); DK 62436 (Chicago); DK 62497 (Cincinnati); DK 62453 (Denver); DK 62445 (Mt Sinai); DK 62481 (Philadelphia); DK 62466 (Pittsburgh); DK 62500 (San Francisco); DK 62452 (St. Louis); DK 84536 (Indiana); DK 84575 (Seattle); DK 62470 (Houston); DK 84538 (Los Angeles); DK 84585 (Atlanta); DK 62456 (Michigan)
– fundername: NIDDK NIH HHS
  grantid: U01 DK062453
– fundername: NIDDK NIH HHS
  grantid: DK 84536
– fundername: NCATS NIH HHS
  grantid: UL1 TR000150
– fundername: NIDDK NIH HHS
  grantid: U01 DK062445
– fundername: NCATS NIH HHS
  grantid: UL1 TR000006
– fundername: NCATS NIH HHS
  grantid: UL1TR000433
– fundername: NIDDK NIH HHS
  grantid: DK 62436
– fundername: NIDDK NIH HHS
  grantid: DK 62452
– fundername: NCATS NIH HHS
  grantid: UL1 TR000448
– fundername: NCATS NIH HHS
  grantid: UL1TR000130
GroupedDBID ---
--K
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
186
1B1
1CY
1L6
1OB
1OC
1ZS
1~5
24P
31~
33P
3O-
3SF
3WU
4.4
4G.
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
7-5
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEDT
AAESR
AAEVG
AAHHS
AALRI
AANHP
AAONW
AAQFI
AAQQT
AAQXK
AASGY
AAXRX
AAXUO
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABLJU
ABMAC
ABOCM
ABPVW
ABWVN
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACLDA
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADMUD
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AECAP
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFFNX
AFGKR
AFPWT
AFUWQ
AFZJQ
AHMBA
AIACR
AIURR
AIWBW
AJAOE
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
F00
F01
F04
F5P
FD8
FDB
FEDTE
FGOYB
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HHY
HHZ
HVGLF
HZ~
IHE
IX1
J0M
J5H
JPC
KBYEO
KQQ
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M41
M65
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
NNB
NQ-
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
R2-
RGB
RIG
RIWAO
RJQFR
ROL
RPZ
RWI
RX1
RYL
SEW
SSZ
SUPJJ
TEORI
UB1
V2E
V9Y
W2D
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
X7M
XG1
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
ABJNI
ACZKN
AFNMH
AGQPQ
AHQVU
CITATION
MEWTI
WXSBR
ACIJW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TM
7TO
7U9
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
7X8
ID FETCH-LOGICAL-c3882-f6ed8a3dbc51f5dbab31a82fdf802f476bb01dae3a60ed6d6427bc2ab0d2b7503
IEDL.DBID DR2
ISSN 0270-9139
1527-3350
IngestDate Thu Jul 10 22:20:59 EDT 2025
Fri Jul 25 22:55:07 EDT 2025
Thu Apr 03 07:03:39 EDT 2025
Thu Apr 24 23:07:57 EDT 2025
Tue Jul 01 03:33:36 EDT 2025
Wed Jan 22 17:07:41 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License 2013 by the American Association for the Study of Liver Diseases.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3882-f6ed8a3dbc51f5dbab31a82fdf802f476bb01dae3a60ed6d6427bc2ab0d2b7503
Notes Potential conflict of interest: Dr. Haber owns stock in Merck. Dr. Molleston received grants from Schering‐Plough, Roche, Bristol‐Myers Squibb, and Vertex. Dr. Murray owns stock in Merck and received grants from Roche and Gilead. Dr. Romero received grants from Bristol‐Myers Squibb. Dr. Rosenthal consults for Merck, General Electric, and Ikaria and received grants from Bristol‐Myers Squibb, Vertex, and Gilead. Dr. Schwarz received grants from Roche. Dr. Sokol consults and owns stock in Yasoo Health and also consults for Roche and Ikaria.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://hdl.handle.net/2027.42/100275
PMID 23703680
PQID 1446936769
PQPubID 996352
PageCount 8
ParticipantIDs proquest_miscellaneous_1490898612
proquest_journals_1446936769
pubmed_primary_23703680
crossref_citationtrail_10_1002_hep_26512
crossref_primary_10_1002_hep_26512
wiley_primary_10_1002_hep_26512_HEP26512
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2013
2013-11-00
2013-Nov
20131101
PublicationDateYYYYMMDD 2013-11-01
PublicationDate_xml – month: 11
  year: 2013
  text: November 2013
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Hepatology (Baltimore, Md.)
PublicationTitleAlternate Hepatology
PublicationYear 2013
Publisher Wolters Kluwer Health, Inc
Publisher_xml – name: Wolters Kluwer Health, Inc
References 44
2004; 22
2002; 36
1990; 31
2004; 20
1993; 45
2010; 19
2011; 53
2009; 374
2011; 31
2009; 29
2010; 88
1993; 14
2004; 114
2004; 39
2010; 152A
2006; 26
2005; 5
2011; 41
1994; 15
2000; 123
2006; 149
2009; 3
2010; 52
2012; 21
2007; 27
2001; 116
2003; 67
Matthews (R10-22-20241201) 2011; 53
Anaya (R25-22-20241201) 2006; 26
Yang (R2-22-20241201) 2010; 52
Kim (R15-22-20241201) 2011; 41
Davenport (R1-22-20241201) 2006; 149
Rasmussen (R14-22-20241201) 2003; 67
Parker (R16-22-20241201) 2010; 88
Yoon (R13-22-20241201) 2001; 116
Feldman (R27-22-20241201) 2012; 21
Muraji (R6-22-20241201) 2009; 3
Bogdanos (R26-22-20241201) 2009; 29
Guttman (R22-22-20241201) 2011; 31
Rose (R23-22-20241201) 1993; 14
LeyvaVega (R8-22-20241201) 2010; 152A
Herrmann (R18-22-20241201) 2004; 39
Broadley (RU24-22-20241201) 2000; 123
GarciaBarcelo (R9-22-20241201) 2010; 19
Amae (RU19-22-20241201) 2004; 20
Zerin (R20-22-20241201) 1994; 15
Carmi (R21-22-20241201) 1993; 45
Mack (R7-22-20241201) 2007; 27
De Tommaso (R3-22-20241201) 2005; 5
Shivakumar (R5-22-20241201) 2004; 114
Hartley (R12-22-20241201) 2009; 374
Riccabona (R17-22-20241201) 2004; 22
24761441 - Z Gastroenterol. 2014 Mar;52(3):251-2.
References_xml – volume: 52
  start-page: 569
  year: 2010
  end-page: 572
  article-title: Implication of early‐onset biliary atresia and extrahepatic congenital anomalies
  publication-title: Pediatr Int
– volume: 31
  start-page: 1485
  year: 2011
  end-page: 1493
  article-title: Biliary atresia with associated structural malformations in Canadian infants
  publication-title: Liver Int
– volume: 149
  start-page: 393
  year: 2006
  end-page: 400
  article-title: The biliary atresia splenic malformation syndrome: a 28 year single‐center retrospective study
  publication-title: J Pediatr
– volume: 31
  year: 1990
– volume: 45
  start-page: 683
  year: 1993
  end-page: 693
  article-title: Extrahepatic biliary atresia and associated anomalies: etiologic heterogeneity suggested by distinctive patterns of associations
  publication-title: Am J Med Genet
– volume: 26
  start-page: 208
  year: 2006
  end-page: 214
  article-title: Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus
  publication-title: J Autoimmun
– volume: 41
  start-page: 227
  year: 2011
  end-page: 232
  article-title: Heterotaxy syndrome
  publication-title: Korean Circ J
– volume: 36
  start-page: 904
  issue: 4 Pt 1
  year: 2002
  end-page: 912
  article-title: The significant human jagged 1 mutations detected in severe cases of biliary atresia
  publication-title: Hepatology
– volume: 21
  start-page: 192
  year: 2012
  end-page: 200
  article-title: Biliary atresia: cellular dynamics and immune dysregulation
  publication-title: Semin Pediatr Surg
– volume: 116
  start-page: 32
  year: 2001
  end-page: 40
  publication-title: Public Health Rep
– volume: 20
  start-page: 380
  year: 2004
  end-page: 383
  article-title: Biliary atresia with associated complicated anorectal and urogenital malformations
  publication-title: Pediatr Surg Int
– volume: 29
  start-page: 241
  year: 2009
  end-page: 253
  article-title: Autoantibodies and their antigens in autoimmune hepatitis
  publication-title: Semin Liver Dis
– volume: 39
  start-page: E20
  year: 2004
  end-page: E22
  article-title: Extrahepatic biliary atresia and caudal regression syndrome in an infant of a diabetic mother
  publication-title: J Pediatr Surg
– volume: 22
  start-page: 73
  year: 2004
  end-page: 78
  article-title: Assessment and management of newborn hydronephrosis
  publication-title: World J Urol
– volume: 152A
  start-page: 886
  year: 2010
  end-page: 895
  article-title: Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3
  publication-title: Am J Med Genet Part A
– volume: 53
  start-page: 905
  year: 2011
  end-page: 914
  article-title: DNA hypomethylation causes bile duct defects in zebrafish and is a distinguishing feature of infantile biliary atresia
  publication-title: Hepatology
– volume: 88
  start-page: 1008
  year: 2010
  end-page: 1016
  article-title: Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004–2006
  publication-title: Birth Defects Res (Part A) Clin Mol Teratol
– volume: 123
  start-page: 1102
  year: 2000
  end-page: 1111
  article-title: Autoimmune disease in first‐degree relatives of patients with multiple sclerosis: a UK survey
  publication-title: Brain
– volume: 15
  start-page: 306
  year: 1994
  end-page: 316
  article-title: Hydronephrosis in the neonate and young infant
  publication-title: Curr Concept Semin Ultrasound CT MR
– volume: 114
  start-page: 322
  year: 2004
  end-page: 329
  article-title: Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN‐gamma in experimental biliary atresia
  publication-title: J Clin Invest
– volume: 19
  start-page: 2917
  year: 2010
  end-page: 2925
  article-title: Genome‐wide association study identifies a susceptibility locus for biliary atresia on 10q24.2.*
  publication-title: Hum Mol Genet
– volume: 14
  start-page: 426
  year: 1993
  end-page: 430
  article-title: Defining criteria for autoimmune diseases (Witebsky's postulates revisted)
  publication-title: Immun Today
– volume: 374
  start-page: 1704
  year: 2009
  end-page: 17013
  article-title: Biliary atresia
  publication-title: Lancet
– volume: 5
  start-page: 108
  year: 2005
  article-title: High frequency of human cytomegalovirus DNA in the liver of infants with extrahepatic neonatal cholestasis
  publication-title: BMC Infect Dis
– volume: 3
  start-page: 599
  year: 2009
  end-page: 606
  article-title: Biliary atresia: a new immunological insight into etiopathogenesis
  publication-title: Expert Rev Gastroenterol Hepatol
– volume: 44
  start-page: 1231
  end-page: 1239
  article-title: Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia
  publication-title: Hepatology
– volume: 27
  start-page: 233
  year: 2007
  end-page: 242
  article-title: The pathogenesis of biliary atresia: evidence for a virus‐induced autoimmune disease
  publication-title: Semin Liver Dis
– volume: 67
  start-page: 193
  year: 2003
  end-page: 201
  article-title: National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study
  publication-title: Birth Defects Res (Part A) Clin Mol Teratol
– volume: 5
  start-page: 108
  year: 2005
  ident: R3-22-20241201
  article-title: High frequency of human cytomegalovirus DNA in the liver of infants with extrahepatic neonatal cholestasis.
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-5-108
– volume: 116
  start-page: 3240
  issue: Suppl 1
  year: 2001
  ident: R13-22-20241201
  article-title: The National Birth Defects Prevention Study.
  publication-title: Public Health Rep
– volume: 31
  start-page: 14851493
  year: 2011
  ident: R22-22-20241201
  article-title: ; the Canadian Pediatric Hepatology Research Group. Biliary atresia with associated structural malformations in Canadian infants.
  publication-title: Liver Int
  doi: 10.1111/j.1478-3231.2011.02578.x
– volume: 88
  start-page: 10081016
  year: 2010
  ident: R16-22-20241201
  article-title: ; National Birth Defects Prevention Network. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006.
  publication-title: Birth Defects Res (Part A) Clin Mol Teratol
– volume: 22
  start-page: 7378
  year: 2004
  ident: R17-22-20241201
  article-title: Assessment and management of newborn hydronephrosis.
  publication-title: World J Urol
  doi: 10.1007/s00345-004-0405-0
– volume: 114
  start-page: 322329
  year: 2004
  ident: R5-22-20241201
  article-title: Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFNgamma in experimental biliary atresia.
  publication-title: J Clin Invest
  doi: 10.1172/JCI200421153
– volume: 45
  start-page: 683693
  year: 1993
  ident: R21-22-20241201
  article-title: Extrahepatic biliary atresia and associated anomalies: etiologic heterogeneity suggested by distinctive patterns of associations.
  publication-title: Am J Med Genet
  doi: 10.1002/ajmg.1320450606
– volume: 123
  start-page: 11021111
  year: 2000
  ident: RU24-22-20241201
  article-title: Autoimmune disease in firstdegree relatives of patients with multiple sclerosis: a UK survey.
  publication-title: Brain
  doi: 10.1093/brain/123.6.1102
– volume: 14
  start-page: 426430
  year: 1993
  ident: R23-22-20241201
  article-title: Defining criteria for autoimmune diseases (Witebskys postulates revisted).
  publication-title: Immun Today
  doi: 10.1016/0167-5699(93)90244-F
– volume: 3
  start-page: 599606
  year: 2009
  ident: R6-22-20241201
  article-title: Biliary atresia: a new immunological insight into etiopathogenesis.
  publication-title: Expert Rev Gastroenterol Hepatol
  doi: 10.1586/egh.09.61
– volume: 26
  start-page: 208214
  year: 2006
  ident: R25-22-20241201
  article-title: Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus.
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2006.01.001
– volume: 53
  start-page: 905914
  year: 2011
  ident: R10-22-20241201
  article-title: DNA hypomethylation causes bile duct defects in zebrafish and is a distinguishing feature of infantile biliary atresia.
  publication-title: Hepatology
  doi: 10.1002/hep.24106
– volume: 67
  start-page: 193201
  year: 2003
  ident: R14-22-20241201
  article-title: ; National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study.
  publication-title: Birth Defects Res (Part A) Clin Mol Teratol
– volume: 29
  start-page: 241253
  year: 2009
  ident: R26-22-20241201
  article-title: Autoantibodies and their antigens in autoimmune hepatitis.
  publication-title: Semin Liver Dis
  doi: 10.1055/s-0029-1233533
– volume: 20
  start-page: 380383
  year: 2004
  ident: RU19-22-20241201
  article-title: Biliary atresia with associated complicated anorectal and urogenital malformations.
  publication-title: Pediatr Surg Int
  doi: 10.1007/s00383-004-1203-x
– volume: 41
  start-page: 227232
  year: 2011
  ident: R15-22-20241201
  article-title: Heterotaxy syndrome.
  publication-title: Korean Circ J
– volume: 374
  start-page: 170417013
  year: 2009
  ident: R12-22-20241201
  article-title: Biliary atresia.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(09)60946-6
– volume: 149
  start-page: 393400
  year: 2006
  ident: R1-22-20241201
  article-title: Underhill, MieliVergani G, Portmann B, Hadzic N. The biliary atresia splenic malformation syndrome: a 28 year singlecenter retrospective study.
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2006.05.030
– volume: 27
  start-page: 233242
  year: 2007
  ident: R7-22-20241201
  article-title: The pathogenesis of biliary atresia: evidence for a virusinduced autoimmune disease.
  publication-title: Semin Liver Dis
  doi: 10.1055/s-2007-985068
– volume: 19
  start-page: 29172925
  year: 2010
  ident: R9-22-20241201
  article-title: Genomewide association study identifies a susceptibility locus for biliary atresia on 10q24.2..
  publication-title: Hum Mol Genet
– volume: 15
  start-page: 306316
  year: 1994
  ident: R20-22-20241201
  article-title: Hydronephrosis in the neonate and young infant.
  publication-title: Curr Concept Semin Ultrasound CT MR
– volume: 52
  start-page: 569572
  year: 2010
  ident: R2-22-20241201
  article-title: Implication of earlyonset biliary atresia and extrahepatic congenital anomalies.
  publication-title: Pediatr Int
  doi: 10.1111/j.1442-200X.2009.03014.x
– volume: 39
  start-page: E20E22
  year: 2004
  ident: R18-22-20241201
  article-title: Extrahepatic biliary atresia and caudal regression syndrome in an infant of a diabetic mother.
  publication-title: J Pediatr Surg
  doi: 10.1016/j.jpedsurg.2003.09.044
– volume: 152A
  start-page: 886895
  year: 2010
  ident: R8-22-20241201
  article-title: Genomic alterations in biliary atresia suggest region of potential disease susceptibility in 2q37.3.
  publication-title: Am J Med Genet Part A
– volume: 21
  start-page: 192200
  year: 2012
  ident: R27-22-20241201
  article-title: Biliary atresia: cellular dynamics and immune dysregulation.
  publication-title: Semin Pediatr Surg
  doi: 10.1053/j.sempedsurg.2012.05.003
– reference: 24761441 - Z Gastroenterol. 2014 Mar;52(3):251-2.
SSID ssj0009428
Score 2.4716506
Snippet The etiology of biliary atresia (BA) is unknown. Given that patterns of anomalies might provide etiopathogenetic clues, we used data from the North American...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1724
SubjectTerms Abnormalities, Multiple - epidemiology
Adult
Biliary Atresia - etiology
Defects
Female
Hepatology
Humans
Male
Prospective Studies
United States - epidemiology
Title Extrahepatic Anomalies in Infants With Biliary Atresia: Results of a Large Prospective North American Multicenter Study
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.26512
https://www.ncbi.nlm.nih.gov/pubmed/23703680
https://www.proquest.com/docview/1446936769
https://www.proquest.com/docview/1490898612
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQh4pLS0tLly6VQT30ksVxYm9CTwtatKBSIVRUDpUiP0XUbYJ2syrw6-txHiteUtVbJDu245mxZzIz3yD0iTGmWBKawDpucAaKVIHQoQiYNqF1HGIkgwTn0298chGfXLLLFfSlzYWp8SG6H24gGf68BgEXcr63BA29MtcDypmvMAyxWqAQnS-ho9LY11V1VhcB73LaogoRute9ef8ueqRg3tdX_YVz9Ar9bJdax5n8GiwqOVB3D1Ac__Nb1tHLRhHFo5pzXqMVU7xBL04bV_sG-jO-qdxBZCDiWuFRUf52GruZ47zAx4WF6Bn8I6-u8EE-zd3EeARJJ7nYx-dmvpi61tJigb9CoDk-m5VtRif2jiLcOoqwTwCGCFEzwxDTePsWXRyNvx9OgqZKQ6AiUM8tNzoRkZaKOepqKWQUioRabRNCbTzkUpJQCxMJTozm2hk8Q6mokERTCV7Ud2i1KAvzHmFulEh1aL3SQBKVpPGQKRmrIRFuIN5Dn1t6ZaqBMIdKGtOsBl-mmduVzG9kD-12Xa9r3I6nOvVbomeN6M4zMJBTwLFLe2ina3ZCB54UUZhyAX3AXZpwGGKzZpZuFhoBpllC3GI9yZ-fPpuMz_zD1r93_YDWKBTk8NmQfbRazRZm26lFlfzo-f8vkSUJZg
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgGXQnm025ZiEAcu2TpO7E0QlwW22sJuVVWt6KWK_FSjbpNqN6sCvx6P86jKQ0LcItmxE8-MPeOZ-QahN4wxxZLQBNZxgzNQpAqEDkXAtAmt4xAjGSQ4Tw_5-DT-fMbOVtD7NhemxofoLtxAMvx-DQIOF9J7t6ihF-a6TzmDEsP3oKI3IOd_Or4Fj0pjX1nV2V0E_MtpiytE6F736t3T6DcV867G6o-c_UfovP3YOtLksr-sZF_9-AXH8X__5jFaa3RRPKyZZx2tmOIJuj9tvO1P0c3oW-X2IgNB1woPi_LKKe1mgfMCHxQWAmjw17y6wB_yWe5mxkPIO8nFO3xsFsuZay0tFngCseb4aF62SZ3Y-4pw6yvCPgcYgkTNHENY4_dn6HR_dPJxHDSFGgIVgYZuudGJiLRUzBFYSyGjUCTUapsQauMBl5KEWphIcGI0187mGUhFhSSaSnCkPkerRVmYTYS5USLVofV6A0lUksYDpmSsBkS4gXgPvW0JlqkGxRyKacyyGn-ZZm5VMr-QPfS663pdQ3f8qdNOS_Wskd5FBjZyClB2aQ-96pqd3IEzRRSmXEIf8JgmHIbYqLmlm4VGAGuWEPexnuZ_nz4bj478w9a_d32JHoxPppNscnD4ZRs9pFCfwydH7qDVar40L5yWVMldLww_ARmQDYI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemIU28MNiAFQZ4iAde0jlO7CbsqbBWHWxTNTGxB6TIn1q0klRtKj7--vmcj2kDJMRbJDu247uz73J3v0PoDWNMsSQ0gXXc4AwUqQKhQxEwbULrOMRIBgnOJ6d8ch5_vGAXa-igzYWp8SG6H24gGf68BgGfa7t_Axp6aeZ9yhlUGL4Xc5JC3YbDsxvsqDT2hVWd2UXAvZy2sEKE7nev3r6MftMwbyus_sYZb6Kv7VrrQJOr_qqSffXrDozjf37MQ_Sg0UTxsGadR2jNFFto46TxtW-j76MflTuJDIRcKzwsym9OZTdLnBf4qLAQPoO_5NUlfp_PcjcxHkLWSS7e4TOzXM1ca2mxwMcQaY6ni7JN6cTeU4RbTxH2GcAQImoWGIIafz5G5-PR5w-ToCnTEKgI9HPLjU5EpKVijrxaChmFIqFW24RQGw-4lCTUwkSCE6O5dhbPQCoqJNFUghv1CVovysLsIMyNEqkOrdcaSKKSNB4wJWM1IMINxHvobUuvTDUY5lBKY5bV6Ms0c7uS-Y3soddd13kN3PGnTrst0bNGdpcZWMgpANmlPbTXNTupA1eKKEy5gj7gL004DPG0ZpZuFhoBqFlC3GI9yf8-fTYZTf3Ds3_v-gptTA_H2fHR6afn6D6F4hw-M3IXrVeLlXnhVKRKvvSicA3sywwx
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extrahepatic+Anomalies+in+Infants+With+Biliary+Atresia%3A+Results+of+a+Large+Prospective+North+American+Multicenter+Study&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Schwarz%2C+Kathleen+B.&rft.au=Haber%2C+Barbara+H.&rft.au=Rosenthal%2C+Philip&rft.au=Mack%2C+Cara+L.&rft.date=2013-11-01&rft.issn=0270-9139&rft.volume=58&rft.issue=5&rft.spage=1724&rft.epage=1731&rft_id=info:doi/10.1002%2Fhep.26512&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_hep_26512
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon